[{"Assets_0_Q3_USD":439443000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":39842000.0,"NetIncomeLoss_1_Q3_USD":5037000.0,"NetIncomeLoss_3_Q3_USD":10064000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":11804000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":11767000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":11706000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":11659000.0,"StockholdersEquity_0_Q3_USD":192465000.0,"EarningsPerShareBasic_1_Q3_USD":0.43,"EarningsPerShareBasic_3_Q3_USD":0.85,"EarningsPerShareDiluted_1_Q3_USD":0.42,"EarningsPerShareDiluted_3_Q3_USD":0.85,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":50703000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":144454000.0,"Ticker":"ANIP","CIK":"1023024","name":"ANI PHARMACEUTICALS INC","OfficialName":"ANI Pharmaceuticals Inc.","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"569805985.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20181106"}]